Breast cancer
Results
Pilot
This study looked at a drug called ulipristal acetate to prevent breast cancer for women who have an increased risk of developing it.
The study was open for people to join between 2016 and 2019. The team presented the results at a conference in 2023.
Ulipristal acetate is pronounced ul-pris-tal ass-e-tate.
Recruitment start: 15 March 2016
Recruitment end: 31 March 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Sacha Howell
Breast Cancer Now
NIHR Clinical Research Network: Cancer
University Hospital of South Manchester (UHSM)
Last reviewed: 23 January 2025
CRUK internal database number: 13342